Drug that cuts off tumor's blood supply extends lives of colorectal cancer patients

A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

The results of the study, done at UCLA's Jonsson Cancer Center and several other sites nationwide, appear June 3, 2004 in the New England Journal of Medicine.

The study paired the angiogenesis inhibitor Avastin, approved by the U.S. Food and Drug Administration in February for use in colorectal cancer, with irinotecan, 5-fluorouracil and leucovorin. The combination therapy improved median survival in patients by nearly five months, reducing risk of death by more than 30 percent. It also improved response rates, duration of response and progression-free survival times, said Dr. Fairooz Kabbinavar, a Jonsson Cancer Center researcher and senior author of the study.

"To put this study in the right perspective, up until the year 2000, median survival in patients with advanced colorectal cancer was about 12 months," said Kabbinavar, an associate professor of hematology/oncology who has been working with Avastin for the last 10 to 12 years, both in the lab and in the clinic. "In just four short years, we're now looking at survivals in excess of two years. We've come a long way. Avastin has not only changed the way we treat colorectal cancer, but I believe it will become a part of cancer management for other tumors such as lung, breast and pancreatic cancers."

A tumor cannot grow bigger than a pinhead unless it establishes an independent blood supply through a process called angiogenesis. This process provides the tumor with the oxygen and nutrients it needs to grow and spread. Researchers have theorized that by stopping or cutting off the new blood supply, they can starve and, hopefully, kill the cancer. Researchers had hoped that

Contact: Kim Irwin
University of California - Los Angeles

Page: 1 2 3

Related biology news :

1. Scientists discover gene signature for tumors tendency to spread
2. Experimental drug shown to block mutant protein causing blood disease
3. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
4. A probable cause for high blood pressure identified - shows links with diabetes
5. Probing the surface of white blood cells to enhance immune system medicine
6. Streptococcus infects humans by thwarting blood clotting
7. Strep disrupts blood clotting to infect humans
8. Nucleic acid-amplification testing further safeguards nations blood supply
9. Hopkins scientists use blood proteins to detect ovarian cancer
10. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
11. Oxygen sensing in worms may hold key to healthy blood pressure in humans

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: